273 related articles for article (PubMed ID: 12601623)
1. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
Ferretti G; Bacchetti T; Marotti E; Curatola G
Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
[TBL] [Abstract][Full Text] [Related]
2. Homocysteinylation of low-density lipoproteins (LDL) from subjects with Type 1 diabetes: effect on oxidative damage of human endothelial cells.
Ferretti G; Bacchetti T; Rabini RA; Vignini A; Nanetti L; Moroni C; Mazzanti L
Diabet Med; 2006 Jul; 23(7):808-13. PubMed ID: 16842488
[TBL] [Abstract][Full Text] [Related]
3. Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells.
Ferretti G; Bacchetti T; Moroni C; Vignini A; Nanetti L; Curatola G
J Cell Biochem; 2004 May; 92(2):351-60. PubMed ID: 15108360
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
Perla-Kaján J; Jakubowski H
FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.
Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P
Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288
[TBL] [Abstract][Full Text] [Related]
8. Effect of homocysteinylation on high density lipoprotein physico-chemical properties.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Chem Phys Lipids; 2010 Feb; 163(2):228-35. PubMed ID: 19962972
[TBL] [Abstract][Full Text] [Related]
9. [The role of homocysteine thiolactone in some of human diseases].
Sikora M; Twardowski T; Jakubowski H
Postepy Biochem; 2006; 52(4):417-23. PubMed ID: 17536511
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 and homocysteine metabolism.
Perła-Kaján J; Jakubowski H
Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
[TBL] [Abstract][Full Text] [Related]
12. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
13. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
Gugliucci A; Lunceford N; Kinugasa E; Ogata H; Schulze J; Kimura S
Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
[TBL] [Abstract][Full Text] [Related]
14. Glycation of human high density lipoprotein by methylglyoxal: effect on HDL-paraoxonase activity.
Bacchetti T; Masciangelo S; Armeni T; Bicchiega V; Ferretti G
Metabolism; 2014 Mar; 63(3):307-11. PubMed ID: 24360750
[TBL] [Abstract][Full Text] [Related]
15. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
Kordonouri O; James RW; Bennetts B; Chan A; Kao YL; Danne T; Silink M; Donaghue K
Metabolism; 2001 Jun; 50(6):657-60. PubMed ID: 11398141
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
[TBL] [Abstract][Full Text] [Related]
17. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase levels in gastric cancer.
Akçay MN; Yilmaz I; Polat MF; Akçay G
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxiii-cclxxv. PubMed ID: 15244199
[TBL] [Abstract][Full Text] [Related]
20. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
